Utrecht, Netherlands

Tom Vink

USPTO Granted Patents = 26 

 

Average Co-Inventor Count = 8.5

ph-index = 9

Forward Citations = 299(Granted Patents)


Location History:

  • Alphen a/d Rijn, NL (2016)
  • Alphen aan den Rijn, NL (2015 - 2022)
  • Utrecht, NL (2015 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Tom Vink in Biopharmaceuticals

Introduction

Tom Vink, an accomplished inventor based in Utrecht, Netherlands, has made significant strides in the biopharmaceutical field with a remarkable portfolio of 26 patents. His innovative work focuses primarily on antibody technologies, which are crucial in the development of therapies for various diseases, including neurodegenerative disorders.

Latest Patents

Among Tom Vink's notable patents are the "Heterodimeric antibody Fc-containing proteins and methods for production thereof," which involves the creation of novel heterodimeric antibody-Fc-containing proteins, such as bispecific antibodies. These advancements are essential for enhancing therapeutic efficacy in treating complex diseases. Another significant patent is "Agents, uses and methods for the treatment of synucleinopathy." This invention pertains to novel monoclonal anti-alpha-synuclein antibodies, which are pivotal in the treatment of synucleinopathies, including Parkinson's disease, Diffuse Lewy Body Disease (DLBD), and other related neurodegenerative conditions.

Career Highlights

Tom Vink has held influential positions in renowned companies within the biopharmaceutical sector. His experience includes significant contributions at Genmab A/S and H. Lundbeck A/S, where he has played a vital role in advancing antibody development and therapeutic solutions.

Collaborations

Throughout his career, Tom has collaborated with esteemed colleagues such as Paul Parren and Jan Van De Winkel. These partnerships have further enriched his innovative endeavors, driving forward the development of effective biomedical therapies and enhancing his contributions to the field.

Conclusion

In summary, Tom Vink's innovative spirit and collaborative efforts have led to vital developments in biopharmaceuticals. His extensive patent portfolio and collaborative approach position him as a significant figure in the pursuit of breakthroughs for challenging medical conditions, particularly in the realm of antibody therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…